Combination therapy with liposomal doxorubicin and liposomal vaccine containing E75, an HER-2/neu-derived peptide, reduces myeloid-derived suppressor cells and improved tumor therapy

Publication date: Available online 7 April 2020Source: Life SciencesAuthor(s): Parvin Zamani, Jamshid Gholizadeh Navashenaq, Manouchehr Teymouri, Maryam Karimi, Mohammad Mashreghi, Mahmoud Reza Jaafari

Source: Life Sciences - April 7, 2020 Category: Biology Source Type: research